PFPT
ECYT

Pinnacle Financial Partners (Tennessee)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-220
Closed -$3K – 220
2013
Q3 		$3K Buy
+220
New +$3.48K ﹤0.01% 212

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s ECYT Position: Q4 2013 in Review

Pinnacle Financial Partners (Tennessee) sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2013, closing a stake of 220 shares — an estimated $3K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in ECYT in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 90 funds tracked by Wall St. Rank hold ECYT as of Q4 2013.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Endocyte, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 220 Endocyte, Inc. Common Stock shares in Q4 2013, an estimated $3K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Pinnacle Financial Partners (Tennessee)'s Endocyte, Inc. Common Stock position peaked at $3K in Q3 2013.
  • 90 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2013.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2013, filed 10 Feb 2014.